Sign in →

Test ID KETGP Ketone Disorders Gene Panel, Varies


Ordering Guidance


The recommended first-tier biochemical testing for ketone disorders includes urine organic acids and plasma acylcarnitine profile. Order  OAU / Organic Acids Screen, Urine and ACRN / Acylcarnitines, Quantitative, Plasma.



Shipping Instructions


Specimen preferred to arrive within 96 hours of collection.



Specimen Required


Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. Call 800-533-1710 for instructions for testing patients who have received a bone marrow transplant.

Specimen Type: Whole blood

Container/Tube:

Preferred: Lavender top (EDTA) or yellow top (ACD)

Acceptable: Any anticoagulant

Specimen Volume: 3 mL

Collection Instructions:

1. Invert several times to mix blood.

2. Send specimen in original tube.

Specimen Stability Information: Ambient (preferred)/Refrigerated


Forms

1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available in Special Instructions:

-Informed Consent for Genetic Testing  (T576)

-Informed Consent for Genetic Testing (Spanish) (T826)

2. Molecular Genetics: Biochemical Disorders Patient Information (T527) in Special Instructions

Useful For

Follow up for abnormal biochemical results suggestive of a ketone disorder

 

Establishing a molecular diagnosis for patients with ketone disorders

 

Identifying variants within genes known to be associated with ketone disorders, allowing for predictive testing of at-risk family members

Genetics Test Information

This test utilizes next-generation sequencing to detect single nucleotide and copy number variants in 9 genes associated with ketone disorders: ACAA2, ACAT1, ACAT2, AKT2, BDH1, HMGCL, HMGCS2, OXCT1, SLC16A1. See Targeted Genes and Methodology Details for Ketone Disorders Gene Panel in Special Instructions and Method Description for additional details.

 

Identification of a pathogenic variant may assist with diagnosis, prognosis, clinical management, familial screening, and genetic counseling for ketone disorders.

 

Additional first tier testing may be considered/recommended. For more information see Ordering Guidance.

Method Name

Custom Sequence Capture and Targeted Next-Generation Sequencing followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing.

Reporting Name

Ketone Disorders Gene Panel

Specimen Type

Varies

Specimen Minimum Volume

See Specimen Required

Specimen Stability Information

Specimen Type Temperature Time Special Container
Varies Varies

Reference Values

An interpretive report will be provided.

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.

CPT Code Information

81479

LOINC Code Information

Test ID Test Order Name Order LOINC Value
KETGP Ketone Disorders Gene Panel In Process

 

Result ID Test Result Name Result LOINC Value
608692 Test Description 62364-5
608693 Specimen 31208-2
608694 Source 31208-2
608695 Result Summary 50397-9
608696 Result 82939-0
608697 Interpretation 69047-9
608698 Resources In Process
608699 Additional Information 48767-8
608700 Method 85069-3
608701 Genes Analyzed 48018-6
608702 Disclaimer 62364-5
608703 Released By 18771-6

NY State Approved

No

Day(s) Performed

Varies

Report Available

3 to 4 weeks